News | December 31, 2024
Schizophrenia in Children: Understanding Early-Onset Schizophrenia
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Poor oral health (periodontal disease) impacts nearly 51% of Indians
India has taken the lead in recognising NAFLD as a major non-communicable disease
Subscribe To Our Newsletter & Stay Updated
